Chemplast Sanmar (CHEMPLASTS) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
7 Aug, 2026Executive summary
Q1 FY27 saw consolidated revenue of INR 1,125 crores (₹1,124.66 crore), up 2% year-over-year but down sequentially, amid a volatile global environment and geopolitical events impacting raw material availability and demand.
EBITDA turned negative at INR 115 crores due to sharp increases in input costs and exceptional charges, with PAT loss at INR 176 crores.
Demand for Paste PVC recovered late in the quarter as Middle East supply issues eased, and downstream operating rates improved.
CMCD showed strong recovery with a healthy order book, expanded molecule pipeline, and geographic expansion.
Refrigerant Gas business commenced commercial production of R32, with positive customer feedback and ongoing ramp-up.
Financial highlights
Consolidated revenue was INR 1,125 crores, down from INR 2,900 crores last year, with EBITDA loss of INR 115 crores and PAT loss of INR 176 crores.
Net debt stood at INR 1,419 crores; interest cost around INR 235 crores annually.
Standalone revenues from operations were INR 596 crores (₹592.32 crore) with EBITDA of INR 74 crores.
Exceptional charge of INR 149.92 crores for onerous contracts and inventory writedown in the previous quarter.
Standalone results in the previous quarter included an INR 898 crore impairment provision related to the subsidiary.
Outlook and guidance
Management expects continued demand recovery in Paste PVC, aided by customs duty reinstatement and regulatory measures.
CMCD is on track for its INR 1,000 crore revenue target, with new product opportunities and geographic expansion.
Full ramp-up of R32 Refrigerant Gas capacity expected by fiscal year-end.
Management anticipates a turnaround in profitability from Q3 as high-cost inventory is replaced and market spreads normalize.
Ongoing investments in capacity expansion and new product development to drive future growth.
Latest events from Chemplast Sanmar
- Significant losses and impairments marked the year, but speciality segments remained resilient.CHEMPLASTS
Q4 25/26 - Q3 FY26 saw losses and revenue decline, but capacity expansions and regulatory shifts support recovery.CHEMPLASTS
Q3 25/26 - Q1 FY25 saw strong revenue and profit growth, led by specialty chemicals and CMC expansion.CHEMPLASTS
Q1 24/25 - H1 FY25 revenue up 8% YoY; Q2 margins fell, but anti-dumping duties and tax changes aid outlook.CHEMPLASTS
Q2 24/25 - Revenue and EBITDA rose, losses narrowed, but margin pressures from dumping persist.CHEMPLASTS
Q3 24/25 - FY25 revenue and EBITDA surged, led by specialty chemicals; net loss narrowed despite PVC headwinds.CHEMPLASTS
Q4 24/25 - Q1 FY26 saw a 4% YoY revenue drop, net loss, and one-time tax and revaluation impacts.CHEMPLASTS
Q1 25/26 - Revenue and EBITDA rose, but net losses deepened amid margin and regulatory pressures.CHEMPLASTS
Q2 25/26